Dermatology

• 

  People

  • Administrative Positions

    • Chen, Suephy C, Chair of the Department of Dermatology

  • Professorships

    • Hall III, Russell P., J. Lamar Callaway Distinguished Professor of Dermatology, in the School of Medicine

  • Primary Appointments

    • Alster, Tina Sherry, Consulting Associate in the Department of Dermatology
    • Bahrani, Bahar, Medical Instructor in the Department of Dermatology
    • Beer, Kenneth Robert, Consulting Associate in the Department of Dermatology
    • Bellet, Jane Sanders, Professor of Dermatology
    • Blanchard, Sarah, Assistant Professor of Dermatology
    • Bressler, Elizabeth Schell, Adjunct Associate Professor of Dermatology
    • Bressler, Garrett S., Consulting Associate in the Department of Dermatology
    • Burton III, Claude Shreve, Professor of Dermatology
    • Cardones, Adela Rambi Guanco, Adjunct Associate Professor in the Department of Dermatology
    • Carr II, John Ferguson, Consulting Associate in the Department of Dermatology
    • Chen, Suephy C, Professor of Dermatology
    • Cole, Emily Fahrig, Assistant Professor of Dermatology
    • Cook, Jonathan Lambert, Professor of Dermatology
    • Cox, Sue Ellen, Consulting Associate in the Department of Dermatology
    • Draelos, Zoe Diana, Consulting Professor in the Department of Dermatology
    • Fresco, Amber Ingram, Assistant Professor of Dermatology
    • Hall III, Russell P., Professor of Dermatology
    • Higgins, Steven Patrick, Adjunct Assistant Professor in the Department of Dermatology
    • Jaleel, Tarannum, Assistant Professor of Dermatology
    • Jamison, Megan O'Brien, Assistant Professor of Dermatology
    • Kheterpal, Meenal Kapoor, Associate Professor of Dermatology
    • Kroshinsky, Daniela, Instructor in the Department of Dermatology
    • Lazarus, Gerald Sylvan, Adjunct Professor in the Department of Dermatology
    • Lechler, Terry H., Professor in Dermatology
    • Lesesky, Erin Bialas, Associate Professor of Dermatology
    • Levy, Stanley B., Consulting Associate in the Department of Dermatology
    • Li, Chuan-Yuan, Professor of Dermatology
    • Li, Fang, Assistant Professor in Dermatology
    • Lightner, Virginia Ann, Assistant Consulting Professor of Dermatology
    • MacLeod, Amanda S, Adjunct Associate Professor in the Department of Dermatology
    • Marano, Anne Louise, Assistant Professor of Dermatology
    • McKinley-Grant, Lynn Josette, Consulting Associate in the Department of Dermatology
    • Murray, John Carroll, Professor of Dermatology
    • Myers, Sarah Ann, Professor of Dermatology
    • Nicholas, Matilda Wray, Associate Professor of Dermatology
    • Olsen, Elise Arline, Professor of Dermatology
    • Pavlis, Michelle Bernadette, Associate Professor of Dermatology
    • Pipkin, Clare Alexandra, Associate Professor of Dermatology
    • Polly, Samantha Ashley, Assistant Professor of Dermatology
    • Powers, Jennifer Gloeckner, Adjunct Assistant Professor of Dermatology
    • Prose, Neil Stuart, Professor of Dermatology
    • Raisch, Michael Charles, Clinical Associate in the Department of Dermatology
    • Rao, Caroline Lillian Hebert, Associate Professor of Dermatology
    • Rothstein, Manfred S., Consulting Associate in the Department of Dermatology
    • Shearer, Sabrina Michelle, Assistant Professor of Dermatology
    • Sidhu-Malik, Navjeet Kaur, Consulting Associate in the Department of Dermatology
    • Sodha, Pooja, Consulting Associate in the Department of Dermatology
    • Stamey, Christopher Robert, Assistant Professor of Dermatology
    • Suggs, Amanda Kristine, Assistant Professor of Dermatology
    • Walsh, Rabina Kochar, Assistant Professor of Dermatology
    • Whitley, Melodi Javid, Assistant Professor of Dermatology
    • Wolfe, Sarah Ann, Associate Professor of Dermatology
    • Yeowell, Heather Nina, Professor Emeritus of Dermatology
    • Zhang, Jennifer Yunyan, Professor in Dermatology

  • Secondary Appointments

    • Al-Rohil, Rami Nayef, Associate Professor in Dermatology
    • Puri, Puja Kumari, Adjunct Assistant Professor in the Department of Dermatology
    • Segura, Tatiana, Professor in Dermatology
    • Woodward, Julie Ann, Professor in Dermatology
• 

  Administers Grant

  • 230LE301_Amethyst_
  • A Controlled Double Blind Research Study Of The Bioavailab
  • A MULTICENTER, PHASE 2B, RANDOMIZED, DOUBLE-BLIND, STRATIFIED, VEHICLE-CONTROLLED STUDY EVALUATING THE SAFETY AND EFFICACY OF SIROLIMUS 3.9% TOPICAL GEL IN PREVENTION OF BCCS IN PATIENTS WITH GORLIN SYNDROME
  • A Multi-Center, Randomized, Double-Blind, Placebo-and Active Comparator-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of BMS-986165 in Subjects with Moderate-to-Severe Plaque Psoriasis
  • A Multicenter, Randomized, Double blind, Vehicle-controlled, Phase 2 Efficacy and Safety Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell C
  • A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of LY3041658 in Adults with Moderate-to-Severe Hidradenitis Suppurativa
  • A Multicenter, Randomized, Double-blind, Vehicle-controlled, Phase 3 Efficacy and Safety Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell C
  • A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE SAFETY AND EFFICACY OF PF-04965842 IN SUBJECTS WITH MODERATE TO SEVERE PSORIASIS.
  • A Phase 1 Randomized, Placebo-Controlled, Blinded, Multiple Ascending Dose Study to Evaluate VIB 7734 in Systemic Lupus Erythematosus, Cutaneous Lupus Erythematosus, Sjogren¿s
  • A Phase 1b, Multicenter, Open-Label, Safety, Tolerability, and Activity Study of SYNT001 in Subjects with Chronic Pemphigus (Vulgaris or Foliaceus)
  • A Phase 2, Multi-Center Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients with Advanced Solid Tumors Harboring PTCH1 Loss ofFunction Mutations
  • A Phase 2, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Upadacitinib in Adult Subjects with Moderate to Severe Hidradenitis Suppurativa
  • A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Bimekizumab in Study Participants with Moderate to Severe Hidradenitis Suppurativa
  • A Phase I, Open-Label, Multicenter Trial Exploring the Safety and Tolerability of Autologous Polyclonal Regulatory T Cell Therapy in Adults with Active Pemphigus
  • A Phase I, Open-Label, Multicenter Trial Exploring the Safety and Tolerability of Autologous Polyclonal Regulatory T Cell Therapy in Adults with Active Pemphigus
  • A Prospective, Multicenter, Long-Term Study to Assess the Safety and Efficacy of Nemolizumab (CD14152) in Subjects with Moderate-to-Severe Atopic Dermatitis
  • A Randomized, Double-Blinded, Placebo-Controlled Trial to Investigate the Efficacy, Safety, and Tolerability of Efgartigimod PH20 SC in Adult Patients With Pemphigus (Vulgaris or Foliaceus)
  • A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered Twice-Daily for 6 Months in Adult Subjects
  • A Study to Support Next Generation Sequencing Screening Process of Endeavor Studies in Patients with Advanced Solid Tumors
  • A mechanistic investigation of space radiation-induced carcinogensis
  • A microtubule catastrophe factor regulates stem cell position and number in the skin
  • A phase 3 pivotal study (118161/118169) and open-label extension (118163) to assess the efficacy and safety of nemolizumab (CD14152) in moderate-to-severe atopic dermatitis subjects and associated pr
  • A randomized, part A partial blinded and part B double blinded, placebo-controlled 24-week clinical study to evaluate the efficacy and safety of nomacopan therapy in adult patients with bullous pemphigoid receiving adjunct oral corticosteroid therapy
  • ATP in Skin Immunity
  • An Open-Label Single-Arm Study of Dupilumab in Adolescent and Adult Skin of Color Patients with Moderate-to-Severe Atopic Dermatitis
  • An Open-Label, Multicenter, Follow-up Trial of ARGX-113-1904 to Evaluate the Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Patients With Pemphigus (ADDRESS+)
  • An Open-Label, Proof of Concept Study Designed to Evaluate the Safety, Efficacy and Pharmacodynamic Effect of Bertilimumab in Patients with Newly Diagnosed, Moderate to Extensive Bullous Pemphigoid
  • Anti-PD1 in combination with an inhibitor of PCSK9 to increase MHC class I molecule expression on tumor cells as immunotherapy for NSCLC
  • BI 655066 versus placebo In a Multicenter randomized double-blind study in patients with Moderate to severe cHronic plAque psoriasis evaluatiNg the effiCacy and safety with randomized withdrawal and rE-treatment (IMMhance)
  • BMS-IM011-132-065
  • CSP 562 IPA - Mary Ann Iannacchione
  • CYLD Regulation of Epidermal Growth and Neoplasia
  • Cell Signaling and Gene Regulation in Epidermal Growth and Differentiation
  • Cell and tissue responses to desmosome disruption
  • Characterization Of A New Cell Surface Protein
  • Characterization of Lysyl Hydroxylase Isoforms in Skin
  • Collagen Biosynthesis In Connective Tissue Disease
  • Corrona Psoriasis Registry (Corrona-PSO-500)
  • Dermatitis Herpetiformis & The Mucosal Immune Response
  • Dermatitis Herpetiformis And The Mucosal Immune Response
  • Dermatitis Herpetiformis And The Mucosal Immune Response
  • Dermatitis Herpetiformis And The Mucossal Immune Response
  • Dermatitis herpetiformis and the mucosal immune response
  • Dermatology Training Grant
  • Dermatology Training Program
  • Development of a toolkit to Improve responses to microaggressions in the clinical setting
  • Differentiation Induced Changes in Centrosomes and Microtubule Organization
  • Duke Skin Diseases Research Core Center
  • Duke Skin of Color Fellowship
  • Dynamic Control of Innate Antiviral Immunity in Skin Homeostasis and Inflammation
  • Effect of Dupilumab (anti-IL4R¿) on the Host-Microbe Interface in Atopic Dermatitis ATOPIC DERMATITIS RESEARCH NETWORK (ADRN)
  • Engineering skin as a bioreactor for production and sustained delivery of therapeutic agents to the blood stream for immune augmentation
  • Evaluation of the accuracy of computer-guided laser delivery versus a human-operator for cutaneous applications
  • HIF Genes in Head and Neck Cancer Radiotherapy
  • IL-27 in skin host defense and regeneration
  • Intermediate Cell Functions in Epidermal Development
  • Intestinal Morphogenesis and Differentiation
  • JUN PROTEINS IN EPIDERMAL HOMEOSTASIS AND NEOPLASIA
  • K63-Ubiquitin-mediated cell signal regulation in epidermis
  • Keratinocyte targeted strategies for treatment of cutaneous GVHD
  • Lysyl Hydroxylase - Structure And Regulatory Studies
  • Lysyl Hydroxylase-Structure And Regulatory Studies
  • Lysyl Hydroxylase: Structure And Regulation Studies
  • Lysyl Hydroxylase: Structural And Regulatory Studies
  • Lysyl Hydroxylase: Structure And Regulatory Studies
  • Mechanisms involved in HP802-mediated wound healing
  • Modulation of tumor microenvironment to hinder cancer progression and therapeutic resistance
  • Molecular Mechanisms of Tumor Response to Cytotoxic Chemotherapy
  • Multi-center, double-blind, randomised, placebo-controlled, phase IIb dose-finding study to evaluate efficacy and safety of different subcutaneous doses of BI 655130 in patients with moderate to severe Palmoplantar Pustulosis (PPP)
  • NF-kB, CDK4 and JNK in Epidermal Growth Regulation
  • Necroptotic genes in cancer cellular response to radiation
  • Novel roles of PCSK9 in regulating the tumor immune microenvironment during radiotherapy
  • Pelle-926-301E: A Phase 3, Multicenter, Open-Label Extension Study of Patidegib Topical Gel, 2% in Subjects with Gorlin Syndrome (Basal Cell Nevus Syndrome)
  • Pilot Study Evaluating the Efficacy of a Topical PDE-4 Inhibitor for Morphea
  • Pro-oncogenic roles of apoptotic caspases
  • Qualification of the Methodology to Identify and Measure Basal Cell Carcinomas (BCCs) on the face of patients with Basal Cell Nevus Syndrome (Gorlin Syndrome) or Sporadic BCCs
  • Quantitative Assessment of Disease Severity in Chronic Cutaneous Graft vs Host Disease
  • Racial variation in Sex Steroid effects in Women with Hidradenitis Suppurativa
  • Regulatory Functions of the Differentiated Epidermis
  • Role of Cell Adhesion and the Cytoskeleton in Epidermal Integrity
  • Role of IL-27 signaling in cutaneous regeneration and host defense
  • Role of c-Jun N-terminal kinases in human epidermal homeostasis
  • Safety and Efficacy of Naloxone Lotion for the Relief of Pruritus in Patients with Mycosis Fungoides (MF)
  • Safety, efficacy and pharmacokinetics of CD11301 gel in early stage CTCL
  • Sex hormones in Hidradenitis Suppurativa
  • Spindle Orientation in Skin Development and Homeostasis
  • THE ROLE OF MALT1 IN MELANOMA GROWTH AND METASTASIS
  • Targeting ATM to boost systemic effects of radiotherapy and immunotherapy
  • Targeting Immune Dysregulation in Psoriasis
  • Targeting PCSK9 to enhance immunotherapy of LKB1/STK11-mutant lung cancer
  • Targeting apoptotic caspases to enhance cancer radiotherapy
  • Tenascin Regulation Of Cell Matrix Interactions In Skin
  • Tenascin Regulation Of Cell-Matrix Interactions In Skin
  • The "Phoenix Rising" pathway of tumor repopulation during radiotherapy
  • Traditional Medicine use in Gondar, Ethiopia: Evaluation of the impact on skin diseases.
  • Translational Regulation by Desmosomes
  • UCB Hidradenitis Suppurativa - Extention
  • USCLC/Duke CLRTC Think Tank on Clinical Trials in Primary Cutaneous Lymphoma
  • Ultrasound-Based Device to Guide Treatment of Graft-Versus-Host-Disease using Skin Elasticity as a Biomarker
  • United States Cutaneous Lymphoma Consortium (USCLC) National Cutaneous Lymphoma Registry to Advance and Optimize the Care and Treatment of Patients with Cutaneous Lymphoma

Add data to my Website